2025 annual financial data
Adaptive Biotechnologies 2025 Operating margin
Adaptive Biotechnologies 2025 operating margin with verified reported values.
Direct answer
Operating margin was -20.62%.
Operating income was -57,123,000 USD and net income was -59,499,000 USD.
Operating cash flow was -45,986,000 USD.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 276,976,000 USD
- Operating income
- -57,123,000 USD
- Net income
- -59,499,000 USD
- Operating cash flow
- -45,986,000 USD